Andy Sassine insider trades
Open-market stock purchases and sales by Andy Sassine, Chief Financial Officer at Arcturus Therapeutics Holdings Inc, from SEC Form 4 filings since May 23, 2013.
Track record: 0% of 6 scored buys are up 5% or more since purchase, averaging -45%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- ARCT Arcturus Therapeutics Holdings Inc: 6 buys, 1 sale, last Aug 15, 2025
- ICAD Icad Inc: 18 sales, last Jul 17, 2025
- XCUR Exicure, Inc: other filings, last Jun 2, 2021
- GEMP Gemphire Therapeutics Inc: 2 buys, last Jul 24, 2019
- MYAN MYnd Analytics, Inc: other filings, last Nov 1, 2016
- CNSO MYnd Analytics, Inc: other filings, last Apr 5, 2016
- ACFN Acorn Energy, Inc: 26 buys, last Sep 23, 2014